Research

ECOGENE-21 offers recognized expertise to support your clinical research projects. Our team works with you to ensure scientific rigor, operational efficiency, and regulatory compliance.

Clinical study execution

ECOGENE-21 has solid experience implementing clinical trials from phase I to IV, including proof-of-concept (PoC) studies, and offers services such as:

- Participant recruitment and follow-up ;
- Coordination of clinical visits ;
- Collecte et traitement des données cliniques ;
- Collection and processing of clinical data ;
- Participant safety monitoring ;
- Management of biobanks and biological samples.

30+

Years of experience
35+

Clinical studies conducted per year
40+

Pharmaceutical, biotech, and academic partners

We conduct an average of more than thirty clinical studies each year. Thanks to its constant commitment to excellence, ECOGENE-21 has been recognized as the best research site among 750 sites in Canada—an honor that highlights the quality of our work and our rigor in executing research protocols.

Our expertise has also been validated by regulatory authorities, including Health Canada, the European Medicines Agency (EMA), and the United States Food and Drug Administration (FDA), all of which have successfully conducted inspections at our site.

With over 30 years of experience and more than 300 successfully completed clinical studies, our organization has built a reputation for excellence both nationally and internationally.

Our unique expertise in clinical research—renowned for its rigor and high standards of quality—has contributed to significant scientific advances (see our publications) and has helped make practical knowledge available in support of better, patient-centered health (see our achievements).
Over the years, our team has participated in a wide range of clinical studies, paving the way for access to innovative treatments such as:
- Monoclonal antibodies
- Small molecules
- RNA and antisense oligonucleotides
- Gene therapies
- Precision medicine (diagnosis and management tailored to rare or complex diseases)
Thanks to a strong network of healthcare professionals—including general practitioners and specialists (lipidologist, cardiologist, internist, family physician)—ECOGENE-21 now facilitates access to emerging therapies across numerous medical fields, including:
- Lipid disorders: hypercholesterolemia, hypertriglyceridemia, Lp(a), mixed dyslipidemia, etc.
- Metabolic syndrome: obesity, type 2 diabetes, MASH/MAFLD, hypertension
- Cardiovascular diseases: heart failure, peripheral vascular disease, myocardial infarction, etc.
- Neurology: Alzheimer’s disease
- Women’s health: hot flashes
Our center is equipped with all the infrastructure and facilities required to successfully carry out clinical studies, including the most complex ones. All our devices are calibrated annually to rigorously meet industry standards.

We offer the following facilities:
- A welcoming waiting room for participants
- Fully equipped examination rooms
- Offices for physicians
- Offices for nurses and clinical coordinators
- Secure medical archives
- A unit with beds for extensive evaluations (Phase I) or infusions
- A laboratory for sample processing and analysis (calibrated centrifuges at 4°C or room temperature, etc.)
- A restricted-access, temperature-controlled pharmacy
- Secure, temperature-controlled refrigerators (4°C) and freezers (-20°C and -80°C)
- Standard medical equipment for basic participant monitoring
- Specialized devices for advanced evaluations, including:
  - Cardiac ultrasound
  - Cardiopulmonary exercise testing (CPET)
  - Fibroscan
  - Bioimpedance
  - etc.
- Established partnerships for specific procedures (radiology, MRI, standardized meals, etc.)

CRO Services

We offer Contract Research Organization (CRO) services tailored to the needs of the pharmaceutical, biotechnology, and academic research sectors, including: